Puma Biotechnology Inc — Quarterly Financial Statistics (NASDAQ:PBYI) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 11.03 M15.59 M3.6 M14.1 M9.7 M14.4 M 41.8 M Cash from investing activities -259 K2.32 M1.53 M8.19 M-506 K26.98 M 36.19 M Cash from financing activities 11.18 M11.33 M11.33 M11.2 M11.33 M11.33 M 45.2 M Free cash flow 11.01 M15.57 M3.54 M14.08 M9.67 M14.44 M 41.73 M

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Nachrichten

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Puma Biotech: EPS übertrifft Schätzungen um 0,02 $ - Umsatz besser als erwartet

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates

Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com

Puma Biotechnology: SVP Douglas Hunt verkauft Aktien im Wert von 52.695 $

Puma Biotechnology: Finanzvorstand Nougues verkauft Aktien für 64.186 US-Dollar

Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI

Puma biotech CFO Nougues sells $64k in shares

Puma Biotechnologie: CEO verkauft Aktien im Wert von rund 204.000 $